Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer
Author:
Affiliation:
1. Department of Oncology and Department of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, China
2. Department of Foreign Language, Dalian Medical University, Dalian, China
Publisher
IOS Press
Subject
Cancer Research,Genetics,Oncology,General Medicine
Reference20 articles.
1. Precision medicine for cancer with next-generation functional diagnostics;Friedman;Nat Rev Cancer,2015
2. PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer;Brasó-Maristany;Nat Med,2016
3. Triple-negative breast cancer;Foulkes;N Engl J Med,2010
4. Basal-like breast cancer: A critical review;Rakha;J Clin Oncol,2008
5. High expression of ccr7 predicts lymph node metastasis and good prognosis in triple negative breast cancer;Li;Cell Physiol Biochem,2017
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HDAC2 promotes autophagy-associated HCC malignant progression by transcriptionally activating LAPTM4B;Cell Death & Disease;2024-08-15
2. Gastric Carcinoma with low ROR alpha, low E- Cadherin and High LAPTM4B Immunohistochemical Profile; is associated with unfavorable prognosis in Egyptian patients;Journal of Immunoassay and Immunochemistry;2023-11-29
3. LAPTM4B promotes AML progression through regulating RPS9/STAT3 axis;Cellular Signalling;2023-06
4. Gene Expression Behavior of a Set of Genes in Platelet and Tissue Samples from Patients with Breast Cancer;International Journal of Molecular Sciences;2023-05-06
5. Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer;BioMed Research International;2022-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3